HomeCompareJDEPF vs MRK

JDEPF vs MRK: Dividend Comparison 2026

JDEPF yields 2.23% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JDEPF wins by $103.12M in total portfolio value· pulled ahead in Year 2
10 years
JDEPF
JDEPF
● Live price
2.23%
Share price
$35.55
Annual div
$0.79
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$103.18M
Annual income
$94,987,846.53
Full JDEPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JDEPF vs MRK

📍 JDEPF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJDEPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JDEPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JDEPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JDEPF
Annual income on $10K today (after 15% tax)
$189.44/yr
After 10yr DRIP, annual income (after tax)
$80,739,669.55/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JDEPF beats the other by $80,731,341.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JDEPF + MRK for your $10,000?

JDEPF: 50%MRK: 50%
100% MRK50/50100% JDEPF
Portfolio after 10yr
$51.62M
Annual income
$47,498,822.34/yr
Blended yield
92.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JDEPF
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
1.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JDEPF buys
0
MRK buys
0
No recent congressional trades found for JDEPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJDEPFMRK
Forward yield2.23%2.76%
Annual dividend / share$0.79$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$103.18M$56.8K
Annual income after 10y$94,987,846.53$9,798.13
Total dividends collected$102.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: JDEPF vs MRK ($10,000, DRIP)

YearJDEPF PortfolioJDEPF Income/yrMRK PortfolioMRK Income/yrGap
1$11,146$445.75$11,206$366.19$60.00MRK
2← crossover$12,855$928.64$12,650$502.35+$205.00JDEPF
3$15,756$2,001.90$14,407$694.19+$1.3KJDEPF
4$21,446$4,586.53$16,585$967.82+$4.9KJDEPF
5$34,616$11,668.57$19,342$1,363.89+$15.3KJDEPF
6$72,243$35,204.11$22,913$1,947.19+$49.3KJDEPF
7$214,629$137,329.12$27,662$2,823.89+$187.0KJDEPF
8$992,263$762,610.30$34,159$4,173.35+$958.1KJDEPF
9$7,651,755$6,590,033.65$43,337$6,308.80+$7.61MJDEPF
10$103,175,225$94,987,846.53$56,776$9,798.13+$103.12MJDEPF

JDEPF vs MRK: Complete Analysis 2026

JDEPFStock

JDE Peet's N.V., together with its subsidiaries, provides various coffee and tea products and solutions to serve consumer needs worldwide. The company operates through CPG Europe, CPG LARMEA, CPG APAC, Out-of-Home, and Peet's segments. It offers multi-serve coffee, and single-serve and double-shot coffee capsules; and pads and pods, instant coffee, whole beans, ready-to-drink coffee beverages, various leaf and packaged tea, and professional tea products, as well as rents or sells professional solutions and complementary coffee systems. The company sells its products under the Douwe Egberts, Kenco, Peet's, L'OR, Stumptown, TiOra, Gevalia, Pickwick, PILAO, Intelligentsia, Senseo, Jacobs, Moccona, Super, OldTown, Ofçay, Mighty Leaf Tea, and Tassimo brands through CPG and out-of-home sales channels. It operates 505 coffee stores under the Peet's, Intelligentsia, Stumptown, OldTown, and 12Oz brands in the United States, China, Malaysia, and Italy, as well as through webshops, and third-party e-tailers and e-commerce marketplaces. The company serves various businesses, such as hotels, hospitals, restaurants, cruise liners, and retirement homes, as well as distributors for distribution to the customer; and offices, universities, airports, and sports venues. JDE Peet's N.V. was incorporated in 2018 and is headquartered in Amsterdam, the Netherlands.

Full JDEPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JDEPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JDEPF vs SCHDJDEPF vs JEPIJDEPF vs OJDEPF vs KOJDEPF vs MAINJDEPF vs JNJJDEPF vs ABBVJDEPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.